LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
May 12, 2022
Politics, Policy & Law
Russia boycott includes CAR T therapies
Behind Miltenyi Biotec’s decision to stop sales of vectors for CAR T therapy to Russia to protest war
Read More
BioCentury
|
Aug 31, 2018
Clinical News
FDA approves first drug for neurotrophic keratitis
Read More
BioCentury
|
Aug 22, 2018
Company News
FDA approves first drug for neurotrophic keratitis
Read More
BioCentury
|
Aug 16, 2017
Clinical News
EC approves Dompe's Oxervate for keratitis
Read More
BioCentury
|
May 26, 2017
Clinical News
CHMP recommends Dompe's human nerve growth factor for keratitis
Read More
Items per page:
10
1 - 5 of 5